Efficacy and Safety of siRNA JNJ-73763989, Capsid Assembly Modulator JNJ-56136379, Nucleos(t)ide Analog, and Pegylated Interferon Alpha-2a for the Treatment of Chronic Hepatitis B: Week 24 Results From the Phase 2 PENGUIN Study

Conference Reports for NATAP

The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022


Efficacy and Safety of siRNA JNJ-73763989, Capsid Assembly Modulator JNJ-56136379, Nucleos(t)ide Analog, and Pegylated Interferon Alpha-2a for the Treatment of Chronic Hepatitis B: Week 24 Results From the Phase 2 PENGUIN Study

	AASLD 2022 Nov 4-8